TCRT
Alaunos Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.91M
P/E Ratio
—
EPS
$-2.12
Beta
-1.13
52W High
$5.48
52W Low
$1.67
50-Day MA
$2.80
200-Day MA
$2.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
18.48
PEG Ratio
0.58
About Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | 3,000 |
| Gross Profit (TTM) | $-1.44M |
| EBITDA | $-4.13M |
| Operating Margin | -138167.00% |
| Return on Equity | -350.30% |
| Return on Assets | -129.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.27 |
| Price-to-Book | 4.64 |
| Price-to-Sales (TTM) | 1970.00 |
| EV/Revenue | 1872.35 |
| EV/EBITDA | -3.54 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -25.00% |
| Shares Outstanding | $2.44M |
| Float | $1.90M |
| % Insiders | 13.88% |
| % Institutions | 6.53% |
Historical Volatility
HV 10-Day
36.36%
HV 20-Day
37.24%
HV 30-Day
36.34%
HV 60-Day
43.70%
HV Rank
2.4%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026